Abstract
Most secreted proteins in eukaryotes are glycosylated, and after a number of common biosynthesis steps the glycan structures mature in a species-dependent manner. Therefore, human therapeutic proteins produced in plants often carry plant-like rather than human-like glycans, which can affect protein stability, biological function, and immunogenicity. The glyco-engineering of plant-based expression systems began as a strategy to eliminate plant-like glycans and produce human proteins with authentic or at least compatible glycan structures. The precise replication of human glycans is challenging, owing to the absence of a pathway in plants for the synthesis of sialylated proteins and the necessary precursors, but this can now be achieved by the coordinated expression of multiple human enzymes. Although the research community has focused on the removal of plant glycans and their replacement with human counterparts, the presence of plant glycans on proteins can also provide benefits, such as boosting the immunogenicity of some vaccines, facilitating the interaction between therapeutic proteins and their receptors, and increasing the efficacy of antibody effector functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Strasser R (2016) Plant protein glycosylation. Glycobiology 26:926–939
Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631–664
Tarp MA, Clausen H (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780:546–563
Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L (2010) Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 8:564–587
Shaaltiel Y, Tekoah Y (2016) Plant specific N-glycans do not have proven adverse effects in humans. Nat Biotechnol 34:706–708
Bosch D, Castilho A, Loos A, Schots A, Steinkellner H (2013) N-glycosylation of plant-produced recombinant proteins. Curr Pharm Des 19:5503–5512
Mor TS (2015) Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story. Biotechnol Lett 37:2147–2150
Xu C, Ng DT (2015) Glycosylation-directed quality control of protein folding. Nat Rev Mol Cell Biol 16:742–752
Arcalis E, Stadlmann J, Rademacher T, Marcel S, Sack M, Altmann F, Stoger E (2013) Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins. Plant Mol Biol 83:105–117
Abranches R, Marcel S, Arcalis E, Altmann F, Fevereiro P, Stoger E (2005) Plants as bioreactors: a comparative study suggests that Medicago truncatula is a promising production system. J Biotechnol 120:121–134
Drakakaki G, Marcel S, Arcalis E, Altmann F, Gonzalez-Melendi P, Fischer R, Christou P, Stoger E (2006) The intracellular fate of a recombinant protein is tissue dependent. Plant Physiol 141:578–586
Arcalis E, Marcel S, Altmann F, Kolarich D, Drakakaki G, Fischer R, Christou P, Stoger E (2004) Unexpected deposition patterns of recombinant proteins in post-endoplasmic reticulum compartments of wheat endosperm. Plant Physiol 136:3457–3466
Arcalis E, Stadlmann J, Marcel S, Drakakaki G, Winter V, Rodriguez J, Fischer R, Altmann F, Stoger E (2010) The changing fate of a secretory glycoprotein in developing maize endosperm. Plant Physiol 153:693–702
Loos A, Van Droogenbroeck B, Hillmer S, Grass J, Kunert R, Cao J, Robinson DG, Depicker A, Steinkellner H (2011) Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 9:179–192
Schahs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H (2007) Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 5:657–663
Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, Labrou N, Altmann F, Ma J, Stöger E, Capell T, Christou P (2008) Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci U S A 105:3727–3732
Floss DM, Sack M, Arcalis E, Stadlmann J, Quendler H, Rademacher T, Stoger E, Scheller J, Fischer R, Conrad U (2009) Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J 7:899–913
Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, Quendler H, Stiegler G, Kunert R, Fischer R, Stoger E (2008) Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 6:189–201
Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Lainé AC, Gomord V, Faye L (1998) N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol Biol 38:31–48
Kaushal GP, Pastuszak I, Hatanaka K, Elbein AD (1990) Purification to homogeneity and properties of glucosidase II from mung bean seedlings and suspension-cultured soybean cells. J Biol Chem 265:16271–16279
Szumilo T, Kaushal GP, Elbein AD (1986) Purification and properties of glucosidase I from mung bean seedlings. Arch Biochem Biophys 247:261–271
Schoberer J, Strasser R (2017) Plant glyco-biotechnology. Semin Cell Dev Biol 80:133–141
Fitchette-Lainé AC, Gomord V, Chekkafi A, Faye L (1994) Distribution of xylosylation and fucosylation in the plant Golgi apparatus. Plant J 5:673–682
Johnson KD, Chrispeels MJ (1987) Substrate specificities of N-acetylglucosaminyl-, fucosyl-, and xylosyltransferases that modify glycoproteins in the Golgi apparatus of bean cotyledon. Plant Physiol 84:1301–1308
Sturm A, Van Kuik JA, Vliegenthart JF, Chrispeels MJ (1987) Structure, position, and biosynthesis of the high mannose and the complex oligosaccharide side chains of the bean storage protein phaseolin. J Biol Chem 262:13392–13403
Strasser R, Steinkellner H, Borén M, Altmann F, Mach L, Glössl J, Mucha J (1999) Molecular cloning of cDNA encoding N-acetylglucosaminyltransferase II from Arabidopsis thaliana. Glycoconjugate J 16:787–791
Strasser R, Stadlmann J, Svoboda B, Altmann F, Glössl J, Mach L (2005) Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans. Biochem J 387:385–391
Strasser R, Schoberer J, Jin C, Glössl J, Mach L, Steinkellner H (2006) Molecular cloning and characterization of Arabidopsis thaliana Golgi alpha-mannosidase II, a key enzyme in the formation of complex N-glycans in plants. Plant J 45:789–803
Oxley D, Munro SL, Craik DJ, Bacic A (1996) Structure of N-glycans on the S3- and S6-allele stylar self-incompatibility ribonucleases of Nicotiana alata. Glycobiology 6:611–618
Bakker H, Rouwendal GJ, Karnoup AS, Florack DE, Stoopen GM, Helsper JP, van Ree R, van Die I, Bosch D (2006) An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci U S A 103:7577–7582
Zeng Y, Bannon G, Thomas VH, Rice K, Drake R, Elbein A (1997) Purification and specificity of β-1,2-xylosyltransferase, an enzyme that contributes to the allergenicity of some plant proteins. J Biol Chem 272:31340–31347
Strasser R, Altmann F, Mach L, Glössl J, Steinkellner H (2004) Generation of Arabidopsis thaliana plants with complex N-glycans lacking β 1,2-linked xylose and core α-1,3-linked fucose. FEBS Lett 561:132–136
Vitale A, Chrispeels MJ (1984) Transient N-acetylglucosamine in the biosynthesis of phytohemagglutinin: attachment in the Golgi apparatus and removal in protein bodies. Cell Biol 99:133–140
Liebminger E, Veit C, Pabst M, Batoux M, Zipfel C, Altmann F, Mach L, Strasser R (2011) Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J Biol Chem 286:10793–10802
Strasser R, Bondili JS, Schoberer J, Svoboda B, Liebminger E, Glössl J, Altmann F, Steinkellner H, Mach L (2007) Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases. Plant Physiol 145:5–16
Song W, Mentink RA, Henquet MG, Cordewener JH, van Dijk AD, Bosch D, America AH, van der Krol AR (2013) N-glycan occupancy of Arabidopsis N-glycoproteins. J Proteomics 93:343–355
Li H, d’Anjou M (2009) Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol 20:678–684
Gill DJ, Chia J, Senewiratne J, Bard F (2010) Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol 189:843–858
Gill DJ, Clausen H, Bard F (2011) Location, location, location: new insights into O-GalNAc protein glycosylation. Trends Cell Biol 21:149–158
Tian E, Ten Hagen KG (2009) Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconjugate J 26:325–334
Kilcoyne M, Shah M, Gerlach JQ, Bhavanandan V, Nagaraj V, Smith AD, Fujiyama K, Sommer U, Costello CE, Olszewski N, Joshi L (2009) O-glycosylation of protein subpopulations in alcohol-extracted rice proteins. J Plant Physiol 166:219–232
Kishimoto T, Watanabe M, Mitsui T, Hori H (1999) Glutelin basic subunits have a mammalian mucin-type O-linked disaccharide side chain. Arch Biochem Biophys 370:271–277
Seifert GJ, Roberts K (2007) The biology of arabinogalactan proteins. Annu Rev Plant Biol 58:137–161
Stulemeijer IJ, Joosten MH (2008) Post-translational modification of host proteins in pathogen-triggered defence signalling in plants. Mol Plant Pathol 9:545–560
Wilson IBH (2002) Glycosylation of proteins in plants and invertebrates. Curr Opin Struct Biol 12:569–577
Shpak E, Leykam JF, Kieliszewski MJ (1999) Synthetic genes for glycoprotein design and the elucidation of hydroxyproline-O-glycosylation codes. Proc Natl Acad Sci U S A 96:14736–14741
Shpak E, Barbar E, Leykam JF, Kieliszewski MJ (2001) Contiguous hydroxyproline residues direct hydroxyproline arabinosylation in Nicotiana tabacum. J Biol Chem 276:11272–11278
Xu J, Tan L, Goodrum KJ, Kieliszewski MJ (2007) High-yields and extended serum half-life of human interferon alpha2b expressed in tobacco cells as arabinogalactan-protein fusions. Biotechnol Bioeng 97:997–1008
Xu J, Tan L, Lamport DT, Showalter AM, Kieliszewski MJ (2008) The O-hyp glycosylation code in tobacco and Arabidopsis and a proposed role of Hyp-glycans in secretion. Phytochemistry 69:1631–1640
Twyman RM (2013) Principles of proteomics2nd edn. Garland Science, Abingdon, pp 181–190
Harrison RL, Jarvis DL (2006) Protein N-glycosylation in the baculovirus–insect cell expression system and engineering of insect cells to produce mammalianized recombinant glycoproteins. Adv Virus Res 68:159–191
Raju TS (2003) Glycosylation variations with expression systems and their impact on biological activity of therapeutic immunoglobulins. BioProc Int 1(4):44–52
Yoo EM, Yu LJ, Wims LA, Goldberg D, Morrison SL (2010) Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. MAbs 2:320–334
Wilson IBH, Zeleny R, Kolarich D, Staudacher E, Stroop CJ, Kamerling JP, Altmann F (2001) Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology 11:261–274
Bardor M, Faveeuw C, Fitchette AC, Gilbert D, Galas L, Trottein F, Faye L, Lerouge P (2003) Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology 13:427–434
Léonard R, Kolarich D, Paschinger K, Altmann F, Wilson IB (2004) A genetic and structural analysis of the N-glycosylation capabilities of rice and other monocotyledons. Plant Mol Biol 55:631–644
Elbers IJ, Stoopen GM, Bakker H, Stevens LH, Bardor M, Molthoff JW, Jordi WJ, Bosch D, Lommen A (2001) Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves. Plant Physiol 126:1314–1322
Twyman RM, Schillberg S, Fischer R (2012) The production of vaccines and therapeutic antibodies in plants. In: Ma S, Wang A (eds) Molecular farming in plants: recent advances and future prospects. Springer, NY, pp 145–159
Castilho A, Bohorova N, Grass J, Bohorov O, Zeitlin L, Whaley K, Altmann F, Steinkellner H (2011) Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody. PLoS One 6:e26040
Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, Mach L, Glössl J, Weterings K, Pabst M, Steinkellner H (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6:392–402
Raven N, Rasche S, Kuehn C, Anderlei T, Klöckner W, Schuster F, Henquet M, Bosch D, Büchs J, Fischer R, Schillberg S (2015) Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200 L orbitally shaken disposable bioreactor. Biotechnol Bioeng 112:308–321
Dirnberger D, Steinkellner H, Abdennebi L, Remy JJ, van de Wiel D (2001) Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur J Biochem 268:4570–4579
Webster DE, Thomas MC (2012) Post-translational modification of plant-made foreign proteins: glycosylation and beyond. Biotechnol Adv 30:410–418
Fiedler U, Phillips J, Artsaenko O, Conrad U (1997) Optimization of scFv antibody production in transgenic plants. Immunotechnology 3:205–216
Schouten A, Roosien J, van Engelen FA, de Jong GA, Borst-Vrenssen AW, Zilverentant JF, Bosch D, Stiekema WJ, Gommers FJ, Schots A, Bakker J (1996) The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol Biol 30:781–793
Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A 100:8013–8018
Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, Lee YC, Feizi T, Langen H, Nussenzweig MC (2002) Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898–1901
He X, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Gloster TM, Vocadlo DJ, Clarke LA, Qian Y, Kermode AR (2012) Production of α-L-iduronidase in maize for the potential treatment of a human lysosomal storage disease. Nat Commun 3:1062
Arcalis E, Ibl V, Peters J, Melnik S, Stoger E (2014) The dynamic behavior of storage organelles in developing cereal seeds and its impact on the production of recombinant proteins. Front Plant Sci 5:439
Hofbauer A, Stoger E (2013) Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues. Curr Pharm Des 19:5495–5502
Ibl V, Stoger E (2012) The formation, function and fate of protein storage compartments in seeds. Protoplasma 249:379–392
Lending CR, Larkins BA (1989) Changes in the zein composition of protein bodies during maize endosperm development. Plant Cell 1:1011–1023
Shewry PR, Halford NG (2002) Cereal seed storage proteins: structures, properties and role in grain utilization. J Exp Bot 53:947–958
Geli MI, Torrent M, Ludevid D (1994) Two structural domains mediate two sequential events in γ-zein targeting: protein endoplasmic reticulum retention and protein body formation. Plant Cell 6:1911–1922
Llop-Tous I, Madurga S, Giralt E, Marzabal P, Torrent M, Ludevid MD (2010) Relevant elements of a maize gamma-zein domain involved in protein body biogenesis. J Biol Chem 285:35633–35644
Pompa A, Vitale A (2006) Retention of a bean phaseolin/maize gamma-zein fusion in the endoplasmic reticulum depends on disulfide bond formation. Plant Cell 18:2608–2621
Bagga S, Adams H, Kemp JD, Sengupta-Gopalan C (1995) Accumulation of 15-kilodalton zein in novel protein bodies in transgenic tobacco. Plant Physiol 107:13–23
Coleman CE, Herman EM, Takasaki K, Larkins BA (1996) The maize gamma-zein sequesters alpha-zein and stabilizes its accumulation in protein bodies of transgenic tobacco endosperm. Plant Cell 8:2335–2345
Torrent M, Llompart B, Lasserre-Ramassamy S, Llop-Tous I, Bastida M, Marzabal P, Westerholm-Parvinen A, Saloheimo M, Heifetz PB, Ludevid MD (2009) Eukaryotic protein production in designed storage organelles. BMC Biol 7:5
He X, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Kermode AR (2012) Influence of an ER-retention signal on the N-glycosylation of recombinant human alpha-L-iduronidase generated in seeds of Arabidopsis. Plant Mol Biol 79:157–169
Loos A, Van Droogenbroeck B, Hillmer S, Grass J, Pabst M, Castilho A, Kunert R, Liang M, Arcalis E, Robinson DG, Depicker A, Steinkellner H (2011) Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis. Plant Physiol 155:2036–2048
Vamvaka E, Twyman RM, Murad AM, Melnik S, Teh AYH, Arcalis E, Altmann F, Stoger E, Rech E, Ma JKC, Christou P, Capell T (2016) Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12. Plant Biotechnol J 14:97–108
Paris N, Stanley CM, Jones RL, Rogers JC (1996) Plant cells contain two functionally distinct vacuolar compartments. Cell 85:563–572
Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, Tuck H, Perrin Y, Ma JK, Fischer R, Christou P, Stoger E (2005) A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotechnol J 3:115–127
Reggi S, Marchetti S, Patti T, De Amicis F, Cariati R, Bembi B, Fogher C (2005) Recombinant human acid β-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts. Plant Mol Biol 57:101–113
Wright KE, Prior F, Sardana R, Altosaar I, Dudani AK, Ganz PR, Tackaberry ES (2001) Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco. Transgenic Res 10:177–181
Frigerio L, de Virgilio M, Prada A, Faoro F, Vitale A (1998) Sorting of phaseolin to the vacuole is saturable and requires a short C-terminal peptide. Plant Cell 10:1031–1042
Neuhaus JM, Sticher L, Meins Jr F, Boller T (1991) A short C-terminal sequence is necessary and sufficient for the targeting of chitinases to the plant vacuole. Proc Natl Acad Sci U S A 88:10362–10366
Sonnewald U, Brauer M, von Schaewen A, Stitt M, Willmitzer L (1991) Transgenic tobacco plants expressing yeast-derived invertase in either the cytosol, vacuole or apoplast: a powerful tool for studying sucrose metabolism and sink/source interactions. Plant J 1:95–106
Grabowski GA, Golembo M, Shaaltiel Y (2014) Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol Genet Metab 112:1–8
Bock R (2015) Engineering plastid genomes: methods, tools, and applications in basic research and biotechnology. Annu Rev Plant Biol 66:211–241
Delporte A, De Zaeytijd J, De Storme N, Azmi A, Geelen D, Smagghe G, Guisez Y, Van Damme EJ (2014) Cell cycle-dependent O-GlcNAc modification of tobacco histones and their interaction with the tobacco lectin. Plant Physiol Biochem 83:151–158
Remaley AT, Ugorski M, Wu N, Litzky L, Burger SR, Moore JS, Fukuda M, Spitalnik SL (1991) Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression. J Biol Chem 266:24176–24183
Kodama S, Tsujimoto M, Tsuruoka N, Sugo T, Endo T, Kobata A (1993) Role of sugar chains in the in vitro activity of recombinant human interleukin 5. Eur J Biochem 211:903–908
Karnoup AS, Turkelson V, Anderson WH (2005) O-linked glycosylation in maize-expressed human IgA1. Glycobiology 15:965–981
Novak J, Tomana M, Kilian M, Coward L, Kulhavy R, Barnes S, Mestecky J (2000) Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol Immunol 37:1047–1056
Pedersen CT, Loke I, Lorentzen A, Wolf S, Kamble M, Kristensen SK, Munch D, Radutoiu S, Spillner E, Roepstorff P, Thaysen-Andersen M, Stougaard J, Dam S (2017) N-glycan maturation mutants in Lotus japonicus for basic and applied glycoprotein research. Plant J 91:394–407
Strasser R, Altmann F, Steinkellner H (2014) Controlled glycosylation of plant-produced recombinant proteins. Curr Opin Biotechnol 30:95–100
Gomord V, Chamberlain P, Jefferis R, Faye L (2005) Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol 23:559–565
van Ree R (2002) Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allerg Immunol 129:189–197
Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffiss JM (1992) Human natural anti-gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89:1223–1235
Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358:1109–1117
Pastores GM, Shankar SP, Petakov M, Giraldo P, Rosenbaum H, Amato DJ, Szer J, Chertkoff R, Brill-Almon E, Zimran A (2016) Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase. Am J Hematol 91:661–665
Rup B, Alon S, Amit-Cohen BC, Brill Almon E, Chertkoff R, Tekoah Y, Rudd PM (2017) Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems-the taliglucerase alfa story. PLoS One 12:e0186211
Zimran A, Durán G, Giraldo P, Rosenbaum H, Giona F, Petakov M, Terreros Muñoz E, Solorio-Meza SE, Cooper PA, Varughese S, Alon S, Chertkoff R (2016) Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naïve patients with Gaucher disease. Blood Cells Mol Dis, published online ahead of print. https://doi.org/10.1016/j.bcmd.2016.07.002
Zimran A, Durán G, Mehta A, Giraldo P, Rosenbaum H, Giona F, Amato DJ, Petakov M, Muñoz ET, Solorio-Meza SE, Cooper PA, Varughese S, Chertkoff R, Brill-Almon E (2016) Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease. Am J Hematol 91:656–660
Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4:601–606
Ma JKC, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, Cole T, Dale P, van Dolleweerd CJ, Isitt V, Katinger D, Lobedan M, Mertens H, Paul MJ, Rademacher T, Sack M, Hundleby PAC, Stiegler G, Stoger E, Twyman RM, Vcelar B, Fischer R (2015) Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol J 13:1106–1120
Mari A, Ooievaar-de Heer P, Scala E, Giani M, Pirrotta L, Zuidmeer L, Bethell D, van Ree R (2008) Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy 63:891–896
Zeitlin L, Olmsted SS, Moench TR, Co MS, Martinell BJ, Paradkar VM, Russell DR, Queen C, Cone RA, Whaley KJ (1998) A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 16:1361–1364
Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG, Black A, Passmore D, Moldovan-Loomis C, Srinivasan M, Cuison S, Cardarelli PM, Dickey LF (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24:1591–1597
Koprivova A, Stemmer C, Altmann F, Hoffmann A, Kopriva S, Gorr G, Reski R, Decker EL (2004) Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2:517–523
Sourrouille C, Marquet-Blouin E, D’Aoust MA, Kiefer-Meyer MC, Seveno M, Pagny-Salehabadi S, Bardor M, Durambur G, Lerouge P, Vezina L, Gomord V (2008) Downregulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J 6:702–721
Shin YJ, Chong YJ, Yang MS, Kwon TH (2011) Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol J 9:1109–1119
Li J, Stoddard TJ, Demorest ZL, Lavoie PO, Luo S, Clasen BM, Cedrone F, Ray EE, Coffman AP, Daulhac A, Yabandith A, Retterath AJ, Mathis L, Voytas DF, D’Aoust MA, Zhang F (2016) Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production. Plant Biotechnol J 14:533–542
Limkul J, Iizuka S, Sato Y, Misaki R, Ohashi T, Ohashi T, Fujiyama K (2016) The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants. Plant Biotechnol J 14:1682–1694
Forthal DN, Gach JS, Landucci G, Jez J, Strasser R, Kunert R, Steinkellner H (2010) Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol 185:6876–6882
Schuster M, Jost W, Mudde GC, Wiederkum S, Schwager C, Janzek E, Altmann F, Stadlmann J, Stemmer C, Gorr G (2007) In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. Biotechnol J 2:700–708
Parsons J, Altmann F, Arrenberg CK, Koprivova A, Beike AK, Stemmer C, Gorr G, Reski R, Decker EL (2012) Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol J 10:851–861
Shin YJ, Castilho A, Dicker M, Sádio F, Vavra U, Grünwald-Gruber C, Kwon TH, Altmann F, Steinkellner H, Strasser R (2017) Reduced paucimannosidic N-glycan formation by suppression of a specific β-hexosaminidase from Nicotiana benthamiana. Plant Biotechnol J 15:197–206
Jansing J, Sack M, Augustine S, Fischer R, Bortesi L (2018) CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose. Plant Biotechnol J (in press)
Piron R, Santens F, De Paepe A, Depicker A, Callewaert N (2015) Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds. Nat Biotechnol 33:1135–1137
Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226–234
Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466–3473
Takeuchi M, Inoue N, Strickland TW, Kubota M, Wada M, Shimizu R, Hoshi S, Kozutsumi H, Takasaki S, Kobata A (1989) Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 86:7819–7822
Yuen CT, Storring PL, Tiplady RJ, Izquierdo M, Wait R, Gee CK, Gerson P, Lloy P, Cremata JA (2003) Relationships between the N-glycan structures and biological activities of resins produced using different culture conditions and purification procedures. J Haematol 12:511–526
Castilho A, Gattinger P, Grass J, Jez J, Pabst M, Altmann F, Gorfer M, Strasser R, Steinkellner H (2011) N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21:813–823
Frey AD, Karg SR, Kallio PT (2009) Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol J 7:33–48
Karg SR, Frey AD, Kallio PT (2010) Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J Biotechnol 146:54–65
Rouwendal GJ, Wuhrer M, Florack DE, Koeleman CA, Deelder AM, Bakker H, Stoopen GM, van Die I, Helsper JP, Hokke CH, Bosch D (2007) Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17:334–344
Nagels B, Van Damme EJ, Pabst M, Callewaert N, Weterings K (2011) Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol 155:1103–1112
Castilho A, Neumann L, Gattinger P, Strasser R, Vorauer-Uhl K, Sterovsky T, Altmann F, Steinkellner H (2013) Generation of biologically active multi-sialylated recombinant human EPO-Fc in plants. PLOS One 8:e54836
Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci U S A 98:2899–2904
Fujiyama K, Furukawa A, Katsura A, Misaki R, Omasa T, Seki T (2007) Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase. Biochem Biophys Res Commun 358:85–91
Misaki R, Kimura Y, Palacpac NQ, Yoshida S, Fujiyama K, Seki T (2003) Plant cultured cells expressing human β1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. Glycobiology 13:199–205
Palacpac NQ, Yoshida S, Sakai H, Kimura Y, Fujiyama K, Yoshida T, Seki T (1999) Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci U S A 96:4692–4697
Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, Gattinger P, Jez J, Rademacher T, Altmann F, Mach L, Steinkellner H (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 284:20479–20485
Seveno M, Bardor M, Paccalet T, Gomord V, Lerouge P, Faye L (2004) Glycoprotein sialylation in plants? Nat Biotechnol 22:1351–1352 Author reply 1352–1353
Zeleny R, Kolarich D, Strasser R, Altmann F (2006) Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 224:222–227
Bakker H, Routier F, Ashikov A, Neumann D, Bosch D, Gerardy-Schahn R (2008) A CMP-sialic acid transporter cloned from Arabidopsis thaliana. Carbohydr Res 343:2148–2152
Shah MM, Fujiyama K, Flynn CR, Joshi L (2003) Sialylated endogenous glycoconjugates in plant cells. Nat Biotechnol 21:1470–1471
Castilho A, Pabst M, Leonard R, Veit C, Altmann F, Mach L, Glössl J, Strasser R, Steinkellner H (2008) Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol 147:331–339
Misaki R, Fujiyama K, Seki T (2006) Expression of human CMP-N-acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. Biochem Biophys Res Commun 339:1184–1189
Wee EG, Sherrier DJ, Prime TA, Dupree P (1998) Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 10:1759–1768
Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, Gattinger P, Kunert R, Quendler H, Pabst M, Leonard R, Altmann F, Steinkellner H (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285:15923–15930
Kallolimath S, Castilho A, Strasser R, Grünwald-Gruber C, Altmann F, Strubl S, Galuska CE, Zlatina K, Galuska SP, Werner S, Thiesler H, Werneburg S, Hildebrandt H, Gerardy-Schahn R, Steinkellner H (2016) Engineering of complex protein sialylation in plants. Proc Natl Acad Sci U S A 113:9498–9503
Wang J, Zhang Y, Wei J, Zhang X, Zhang B, Zhu Z, Zou W, Wang Y, Mou Z, Ni B, Wu Y (2007) Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 121:174–182
Rouwendal GJ, Florack DE, Hesselink T, Cordewener JH, Helsper JP, Bosch D (2009) Synthesis of Lewis X epitopes on plant N-glycans. Carbohydr Res 344:1487–1493
Werle M, Bernkop-Schnurch A (2006) Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30:351–367
Xu J, Ge X, Dolan MC (2011) Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol Adv 29:278–299
Xu J, Okada S, Tan L, Goodrum KJ, Kopchick JJ, Kieliszewski MJ (2010) Human growth hormone expressed in tobacco cells as an arabinogalactan-protein fusion glycoprotein has a prolonged serum life. Transgenic Res 19:849–867
Daskalova SM, Radder JE, Cichacz ZA, Olsen SH, Tsaprailis G, Mason H, Lopez LC (2010) Engineering of N. benthamiana plants for production of N-acetylgalactosamine-glycosylated proteins—towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. BMC Biotechnol 10:62
Strasser R (2012) Challenges in O-glycan engineering of plants. Front Plant Sci 3:218
Strasser R (2013) Engineering of human-type O-glycosylation in Nicotiana benthamiana plants. Bioengineered 4:191–196
Dicker M, Tschofen M, Maresch D, König J, Juarez P, Orzaez D, Altmann F, Steinkellner H, Strasser R (2016) Transient glyco-engineering to produce recombinant IgA1 with defined N- and O-glycans in plants. Front Plant Sci 7:18
Dicker M, Maresch D, Strasser R (2016) Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants. Bioengineered 22:1–6
Buyel JF, Fischer R (2014) Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants. Biotechnol J 9:566–577
CMC Biotech Working Group (2009) A-Mab: a case study in bioprocess development. CASSS, Emeryville, pp 1–278
Buyel JF, Twyman RM, Fischer R (2015) Extraction and downstream processing of plant-derived recombinant proteins. Biotechnol Adv 33:902–913
Wilken LR, Nikolov ZL (2012) Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 30:419–433
Antonyuk V, Grama S, Plichta Z, Magorivska I, Horak D, Stoika R (2015) Use of specific polysaccharide-immobilized monodisperse poly(glycidyl methacrylate) core-silica shell microspheres for affinity purification of lectins. Biomed Chromatogr 29:783–787
Zhu BCR, Laine RA (1989) Purification of acetyllactosamine-specific tomato lectin by erythroglycan-Sepharose affinity chromatography. Prep Biochem 19:341–350
Souza MA, Carvalho FC, Ruas LP, Ricci-Azevedo R, Roque-Barreira MC (2013) The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties. Glycoconj J 7:641–657
Muthing J, Meisen I, Bulau P, Langer M, Witthohn K, Lentzen H, Neumann U, Peter-Katalinic J (2004) Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues. Biochemistry 11:2996–3007
Endo T (1996) Fractionation of glycoprotein-derived oligosaccharides by affinity chromatography using immobilized lectin columns. J Chromatogr A 720:251–261
Fanayan S, Hincapie M, Hancock WS (2012) Using lectins to harvest the plasma/serum glycoproteome. Electrophoresis 33:1746–1754
Hortin GL (1990) Isolation of glycopeptides containing O-linked oligosaccharides by lectin affinity-chromatography on jacalin agarose. Anal Biochem 191:262–267
Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv 2:434–439
Kourmanova AG, Soudarkina OJ, Olsnes S, Kozlov JV (2004) Cloning and characterization of the genes encoding toxic lectins in mistletoe (Viscum album L). Eur J Biochem 12:2350–2360
Niwa H, Tonevitsky AG, Agapov II, Saward S, Pfuller U, Palmer RA (2003) Crystal structure at 3 Å of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose. Eur J Biochem 13:2739–2749
Boes A, Spiegel H, Delbruck H, Fischer R, Schillberg S, Sack M (2011) Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco. Biotechnol Bioeng 12:2804–2814
Li YC, Pfuller U, Larsson EL, Jungvid H, Galaev IY, Mattiasson B (2001) Separation of mistletoe lectins based on the degree of glycosylation using boronate affinity chromatography. J Chromatogr A 925:115–121
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Fischer, R. et al. (2018). Glyco-Engineering of Plant-Based Expression Systems. In: Rapp, E., Reichl, U. (eds) Advances in Glycobiotechnology. Advances in Biochemical Engineering/Biotechnology, vol 175. Springer, Cham. https://doi.org/10.1007/10_2018_76
Download citation
DOI: https://doi.org/10.1007/10_2018_76
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69589-7
Online ISBN: 978-3-030-69590-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)